Amrize (NYSE:AMRZ – Get Free Report) was downgraded by equities research analysts at Wells Fargo & Company from a “strong-buy” rating to a “hold” rating in a report issued on Wednesday, Zacks reports.
Other equities analysts also recently issued research reports about the company. Morgan Stanley set a $63.00 price target on Amrize and gave the stock an “overweight” rating in a research note on Monday, June 22nd. Zacks Research downgraded shares of Amrize from a “hold” rating to a “strong sell” rating in a research report on Wednesday, August 19th. Royal Bank Of Canada lowered shares of Amrize from a “sector perform” rating to an “underperform” rating and decreased their price objective for the stock from $60.00 to $48.00 in a report on Monday, August 10th. William Blair set a $40.00 target price on shares of Amrize in a research report on Wednesday, September 2nd. Finally, Oppenheimer cut their target price on shares of Amrize from $68.00 to $65.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 21st. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, eight have given a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $55.50.
Get Our Latest Stock Report on AMRZ
Amrize Trading Down 2.3%
Amrize (NYSE:AMRZ – Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.88 earnings per share for the quarter, missing the consensus estimate of $0.92 by ($0.04). The business had revenue of $3.49 billion during the quarter. Amrize had a return on equity of 10.22% and a net margin of 9.89%. Analysts predict that Amrize will post 2.72 EPS for the current year.
Insider Activity at Amrize
In other news, CEO Jan Jenisch acquired 4,000 shares of the stock in a transaction on Wednesday, September 2nd. The stock was acquired at an average price of $42.50 per share, with a total value of $170,000.00. Following the completion of the transaction, the chief executive officer owned 519,000 shares of the company’s stock, valued at $22,057,500. This represents a 0.78% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Jacques Sanche acquired 4,150 shares of the stock in a transaction on Wednesday, August 26th. The shares were purchased at an average cost of $45.02 per share, with a total value of $186,833.00. Following the transaction, the director directly owned 9,766 shares of the company’s stock, valued at approximately $439,665.32. This trade represents a 73.90% increase in their position. The SEC filing for this purchase provides additional information. Insiders purchased a total of 48,983 shares of company stock valued at $2,158,755 over the last ninety days. Insiders own 0.54% of the company’s stock.
Institutional Trading of Amrize
A number of hedge funds and other institutional investors have recently modified their holdings of the business. California State Teachers Retirement System boosted its stake in Amrize by 5,444.5% during the second quarter. California State Teachers Retirement System now owns 30,472,836 shares of the company’s stock worth $1,624,202,000 after acquiring an additional 29,923,230 shares in the last quarter. Norges Bank purchased a new stake in Amrize in the fourth quarter worth about $929,333,000. Harris Associates L P bought a new position in shares of Amrize during the fourth quarter valued at approximately $615,406,000. Wellington Management Group LLP increased its stake in shares of Amrize by 48.8% during the third quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company’s stock valued at $561,018,000 after purchasing an additional 3,809,133 shares in the last quarter. Finally, Marshall Wace LLP lifted its holdings in shares of Amrize by 865.4% during the third quarter. Marshall Wace LLP now owns 2,889,660 shares of the company’s stock valued at $139,436,000 after purchasing an additional 2,590,336 shares during the last quarter.
Amrize Company Profile
Amrize is a North American building materials and solutions company formed through the separation of Holcim’s North American business. The company began trading publicly on the New York Stock Exchange in 2025 under the symbol AMRZ.
Amrize supplies essential construction materials, including cement, aggregates, ready-mix concrete and asphalt. It also provides a range of building products and solutions used in residential, commercial and infrastructure construction, including concrete products, roofing systems and other materials designed to support building and construction projects.
The company serves customers across the United States and Canada through a network of production facilities, distribution operations and local businesses.
Read More
- Five stocks we like better than Amrize
- Sezzle’s BNPL Growth Is Working, But the Stock Comes With a Catch
- Qualcomm’s Data Center Bet Looks More Real After Amazon’s AI Deal
- GE Aerospace’s $11.75B Deal Puts Howmet Aerospace in Focus
- Casey’s Post-Earnings Drop May Give Investors a Better Entry Into a Quality Retailer
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
